Brands and Strategy
We focus on the R&D, design and manufacturing of high-quality diagnostic reagents for infectious diseases, chronic conditions, oncology, genetic disorders, and more. Our product portfolio includes ELISA kits, rapid test strips, molecular diagnostic reagents, and fully automated chemiluminescence systems, catering to hospitals, laboratories, and public health institutions.
Technology-Driven Growth: 15% annual revenue reinvested in R&D for diagnostics and multi-omics platforms.
Global Partnerships: Collaborate with multinational companies, worldwide hospitals and regional distributors to penetrate emerging markets. 